| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2000 | EP0968222A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 01/05/2000 | EP0968221A1 Novel salicylic acid derivatives and their use in cosmetic or dermatological compositions |
| 01/05/2000 | EP0968214A1 Purification process |
| 01/05/2000 | EP0968213A1 Alkynyl-substituted camptothecins and process for their preparation |
| 01/05/2000 | EP0968212A1 Method of making (1s, 4r)-1-azabicyclo 2.2.1]heptan-3-one and (1r, 4s), 1-azabicyclo 2.2.1]heptan-3-one |
| 01/05/2000 | EP0968211A1 Novel tetrazoles |
| 01/05/2000 | EP0968210A1 Method of making arylamino triazolopyridines |
| 01/05/2000 | EP0968209A1 THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 01/05/2000 | EP0968208A1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia |
| 01/05/2000 | EP0968206A1 N-heterocyclic derivatives as nos inhibitors |
| 01/05/2000 | EP0968201A2 New aminopiperazine derivatives |
| 01/05/2000 | EP0968200A1 Calcitonin mimetics |
| 01/05/2000 | EP0968199A1 Antibacterial heterocyclic amino acid derivatives |
| 01/05/2000 | EP0968198A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING $g(b)-AMYLOID PEPTIDE |
| 01/05/2000 | EP0968194A1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 01/05/2000 | EP0968191A1 Phenylbenzimidazole derivatives as ligands for gaba receptors |
| 01/05/2000 | EP0968190A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/05/2000 | EP0968187A1 (-)e-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethyl-piperidine and its antidiarrhoeal use |
| 01/05/2000 | EP0968186A1 Improved polyamides for binding in the minor groove of double stranded dna |
| 01/05/2000 | EP0968183A2 13-thia prostaglandins for use in glaucoma therapy |
| 01/05/2000 | EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/05/2000 | EP0968180A1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii |
| 01/05/2000 | EP0968174A1 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 01/05/2000 | EP0968168A1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 01/05/2000 | EP0968162A1 5-hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/05/2000 | EP0968013A1 Coated implantable medical device |
| 01/05/2000 | EP0967998A2 Polymeric carrier |
| 01/05/2000 | EP0967997A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 01/05/2000 | EP0967993A2 Anti-cocaine vaccine |
| 01/05/2000 | EP0967989A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 01/05/2000 | EP0967985A1 Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals |
| 01/05/2000 | EP0967984A1 Composition and method for treating cancer and immunological disorders resulting in chronic conditions |
| 01/05/2000 | EP0967982A2 Phytosterol composition for preventing alzheimers disease |
| 01/05/2000 | EP0967981A1 Medicament containing betasitosterol and/or phytosterol/betasitosterol mixtures |
| 01/05/2000 | EP0967980A2 Use of aminothiazoles for treating wounds and skin |
| 01/05/2000 | EP0967979A1 The use of levobupivacaine or ropivacaine in treating migraine |
| 01/05/2000 | EP0967978A2 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 01/05/2000 | EP0967977A1 Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimidazole, and optionally a potentiator |
| 01/05/2000 | EP0967976A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 01/05/2000 | EP0967975A1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 01/05/2000 | EP0967974A1 Spermicide |
| 01/05/2000 | EP0967973A2 Mediation of cytokines by melanin |
| 01/05/2000 | EP0967972A1 Extendible transdermal therapeutic system |
| 01/05/2000 | EP0967969A1 Novel antioxidant mixture |
| 01/05/2000 | EP0967968A1 Pharmaceutical or cosmetic composition containing at least one retinoid |
| 01/05/2000 | EP0967967A1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 01/05/2000 | EP0967892A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 01/05/2000 | EP0946173A4 Preparation of 3-fluoro oxindole derivatives |
| 01/05/2000 | EP0817779B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/05/2000 | EP0813403A4 Stable water-in-oil emulsion system |
| 01/05/2000 | EP0800512B1 Antiherpes peptidomimetic compounds |
| 01/05/2000 | EP0746305B1 Sunscreen compositions |
| 01/05/2000 | EP0726902B1 Polycyclic antiparasitic agents, process and strain for their preparation and their use |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | EP0711299B1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS |
| 01/05/2000 | EP0706509B1 Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides |
| 01/05/2000 | EP0676206B1 Antimalarial |
| 01/05/2000 | EP0669128B1 Sustained-release microsphere containing antipsychotic and process for producing the same |
| 01/05/2000 | EP0666856B1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 01/05/2000 | EP0664792B1 Fibrinogen receptor antagonists |
| 01/05/2000 | EP0658344B1 Liposome preparation containing tricyclic compound |
| 01/05/2000 | EP0593595B1 Derivatives of inositol, preparations containing them and their use |
| 01/05/2000 | EP0539420B1 substituted thiazolyl and substituted pyridinyl derivatives |
| 01/05/2000 | EP0427765B1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 01/05/2000 | DE19915954A1 Cyclooxygenaseinhibitor Cyclooxygenase |
| 01/05/2000 | DE19838030C1 Urea-containing dermatological compositions containing diglycerine and lactic acid-sodium lactate buffer |
| 01/05/2000 | DE19831217A1 Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik New porphyrin derivatives, pharmaceutical compositions containing them and their use in photodynamic therapy and MRI diagnosis |
| 01/05/2000 | DE19829844A1 Verwendung von D-Galaktose zur Verhinderung von Nekrosen Use of D-galactose to prevent necrosis |
| 01/05/2000 | DE19829713C1 Therapeutisches System mit Zusatz von Perglanzpigmenten Therapeutic system with the addition of pearlescent pigments |
| 01/05/2000 | DE19829709A1 Zubereitungen zum Schutze der Kleinkinderhaut vor Dermatitis ammoniacalis Preparations for the Protection of Infants skin from dermatitis ammoniacalis |
| 01/05/2000 | DE19829516A1 Wasserlöslicher nativer pflanzlicher Trockenextrakt, insbesondere Gingko biloba Extrakt mit hohem Gehalt an Terpenoiden und Flavonglykosiden Water soluble native plant dry extract, Gingko biloba extract particularly rich in terpenoids and flavone glycosides |
| 01/05/2000 | DE19829014A1 Modifizierter C1-Esterase-Inhibitor zur Blockierung der Infektiosität von HIV Modified C1-esterase inhibitor to block the infectivity of HIV |
| 01/05/2000 | DE19821625C1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 01/05/2000 | DE19818842C1 Cold remedy containing sugar alcohol mixture such as Isomalt, having immunostimulant and antimicrobial activity |
| 01/05/2000 | CN1240450A Thienopyrimidine with phosphodiesterase V inhibiting effect |
| 01/05/2000 | CN1240447A Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin |
| 01/05/2000 | CN1240444A Piperidine derivatives |
| 01/05/2000 | CN1240443A Novel carboxy substituted cyclic carboxamide derivatives |
| 01/05/2000 | CN1240438A Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 01/05/2000 | CN1240437A Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240430A Bis(acridinecarboxamide) and Bis(phenazinecarboxamide) as antitumour agents |
| 01/05/2000 | CN1240428A Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them |
| 01/05/2000 | CN1240427A 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 01/05/2000 | CN1240426A Novel tetrahydrobenzindolone derivatives |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240420A Process for the preparation of NMDA antagonists |
| 01/05/2000 | CN1240419A Aromatic amine derivatives having NOS inhibitory effect |
| 01/05/2000 | CN1240362A Pharmaceutical compositions for freeze drying |
| 01/05/2000 | CN1240361A Use of low molecular weight amino alcohols in ophthalmic compositions |
| 01/05/2000 | CN1240355A Use of protein kinase C inhibitors to enhance the clinical efficary of oncolytic agent and radiation therapy |
| 01/05/2000 | CN1240354A Use of condensated (hetaryl-substituted) 1-benzal-3-pyarzol derivates for treating special diseases of the cardiovascular and the central nerous systems |
| 01/05/2000 | CN1240353A Local anesthetic for external use |
| 01/05/2000 | CN1240352A Salts of acetaminophen |
| 01/05/2000 | CN1240351A Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 01/05/2000 | CN1240350A Transdermal preparation containing serotonin receptor antagonist |
| 01/05/2000 | CN1240349A Stable glassy state powder formulations |
| 01/05/2000 | CN1240348A Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof |
| 01/05/2000 | CN1240347A New aqueous medicament preparations for the production of propellent gas-free aerosols |
| 01/05/2000 | CN1240229A Process for preparing lovastatin-containing red koji mold body |
| 01/05/2000 | CN1240210A Substituted tricyclic compound |